|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 403/14 | (2006.01) |
| C07D 403/14 | (2013.01) | ||
| C07D 401/14 | (2006.01) | ||
| C07D 401/14 | (2013.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61K 31/4709 | (2006.01) |
| (11) | Patento numeris | 3795570 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 20177662.2 |
| Europos patento paraiškos padavimo data | 2020-06-01 | |
| (97) | Europos patento paraiškos paskelbimo data | 2021-03-24 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2022-02-23 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 201962904007 P | 2019-09-23 | US |
| (72) |
FAN, Jie , US
QIAN, Yimin , US
HE, Wei , US
LIU, Ke , US
|
| (73) |
Accutar Biotechnology Inc. ,
760 Parkside Avenue
Room 213, Brooklyn, NY 11226,
US
|
| (54) | SUBSTITUTED QUINOLINE-8-CARBONITRILE DERIVATIVES HAVING ANDROGEN RECEPTOR DEGRADATION ACTIVITY AND USES THEREOF |
| SUBSTITUTED QUINOLINE-8-CARBONITRILE DERIVATIVES HAVING ANDROGEN RECEPTOR DEGRADATION ACTIVITY AND USES THEREOF |